Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Prostate Cancer: Prostate-specific Membrane Antigen Positron-emission Tomography/Computed Tomography or Positron-emission Tomography/Magnetic Resonance Imaging for Staging

Prostate Cancer: Prostate-specific Membrane Antigen Positron-emission Tomography/Computed... Downloaded from http://journals.lww.com/topicsinmri by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/05/2020 REVIEW ARTICLE Prostate Cancer Prostate-specific Membrane Antigen Positron-emission Tomography/Computed Tomography or Positron-emission Tomography/Magnetic Resonance Imaging for Staging Daniela A. Ferraro, MD, and Irene A. Burger, MD association of prostate-specific membrane antigen (PSMA) PET and Abstract: Positron-emission tomography (PET) with prostate-specific MRI is very interesting due to the combination of superior assess- membrane antigen (PSMA) has been increasingly used to image prostate ment of the primary tumor by MRI over CT and the improved cancer in the last decade. In the staging setting several studies have already assessment of pelvic nodes and distant metastases by PSMA PET. been published suggesting PSMA PET can be a valuable tool. They, however, Despite the high cost of the examination and the low availability did not translate into recommendations by guidelines. Both PSMA PET/ of PET/MRI scanners, several original studies have been published in computed tomography (CT) and PET/magnetic resonance imaging have been the last years regarding PSMA PET/MRI for staging. Even though investigated in the staging setting, showing higher detection rate of prostate there is still a lack of literature showing a higher impact on patient cancer lesions over the conventional imaging work-up and some studies http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Topics in Magnetic Resonance Imaging Wolters Kluwer Health

Prostate Cancer: Prostate-specific Membrane Antigen Positron-emission Tomography/Computed Tomography or Positron-emission Tomography/Magnetic Resonance Imaging for Staging

Loading next page...
 
/lp/wolters-kluwer-health/prostate-cancer-prostate-specific-membrane-antigen-positron-emission-vuKKE5ytZO

References (75)

Publisher
Wolters Kluwer Health
ISSN
0899-3459
eISSN
1536-1004
DOI
10.1097/RMR.0000000000000229
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/topicsinmri by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/05/2020 REVIEW ARTICLE Prostate Cancer Prostate-specific Membrane Antigen Positron-emission Tomography/Computed Tomography or Positron-emission Tomography/Magnetic Resonance Imaging for Staging Daniela A. Ferraro, MD, and Irene A. Burger, MD association of prostate-specific membrane antigen (PSMA) PET and Abstract: Positron-emission tomography (PET) with prostate-specific MRI is very interesting due to the combination of superior assess- membrane antigen (PSMA) has been increasingly used to image prostate ment of the primary tumor by MRI over CT and the improved cancer in the last decade. In the staging setting several studies have already assessment of pelvic nodes and distant metastases by PSMA PET. been published suggesting PSMA PET can be a valuable tool. They, however, Despite the high cost of the examination and the low availability did not translate into recommendations by guidelines. Both PSMA PET/ of PET/MRI scanners, several original studies have been published in computed tomography (CT) and PET/magnetic resonance imaging have been the last years regarding PSMA PET/MRI for staging. Even though investigated in the staging setting, showing higher detection rate of prostate there is still a lack of literature showing a higher impact on patient cancer lesions over the conventional imaging work-up and some studies

Journal

Topics in Magnetic Resonance ImagingWolters Kluwer Health

Published: Feb 1, 2020

There are no references for this article.